piracetam has been researched along with physostigmine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (43.75) | 18.7374 |
| 1990's | 6 (37.50) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Darekar, MN; Gurjar, AS; Ooi, L; Yeong, KY | 1 |
| Baĭmanov, TD; Burov, IuV; Maĭsov, NI | 1 |
| Gaál, L; Molnár, P | 1 |
| Burov, IuV; Kadysheva, LV; Robakidze, TN; Shaposhnikova, GI; Voronin, AE | 1 |
| Emilien, G | 1 |
| Genovese, N; Klawans, HL | 1 |
| Davis, KL; Hollander, E; Mohs, RC | 1 |
| Ohtomo, E | 1 |
| Jolles, J; Verhoeven, WM | 1 |
| Gershon, S; Goodnick, P | 1 |
| Bures, J; Buresová, O | 1 |
| Gaál, L; Horváth, C; Molnár, P | 1 |
| Bhattacharya, SK; Jaiswal, AK; Sen, AP; Upadhyay, SN | 1 |
| Mielke, R | 1 |
| de Boissezon, X; de Boysson, C; Démonet, JF; Peran, P | 1 |
6 review(s) available for piracetam and physostigmine
| Article | Year |
|---|---|
Pharmacology of dementia.
Topics: 4-Aminopyridine; Acetylcholine; Adenosine Triphosphate; Aged; Aminopyridines; Central Nervous System Stimulants; Cerebrovascular Circulation; Clinical Trials as Topic; Dementia; Double-Blind Method; Humans; Levodopa; Nafronyl; Narcotic Antagonists; Nerve Tissue Proteins; Parasympathomimetics; Pentylenetetrazole; Physostigmine; Piracetam; Procainamide; Vasodilator Agents; Vasopressins | 1986 |
Cholinergic approaches to the treatment of Alzheimer's disease.
Topics: 4-Aminopyridine; Alanine; Alzheimer Disease; Aminopyridines; Arecoline; Clinical Trials as Topic; Humans; Parasympathomimetics; Physostigmine; Piracetam; Pyrrolidines; Research Design; Succinimides; Synapses | 1986 |
[Recent drug therapy of senile dementia].
Topics: Adrenocorticotropic Hormone; Alzheimer Disease; Choline; Dementia; Dihydroergotoxine; Humans; Narcotic Antagonists; Peptide Fragments; Phosphatidylcholines; Physostigmine; Piracetam; Pyrrolidines; Succinimides | 1987 |
[Psychopharmacologic treatment of cognitive function disorders in aging persons: current possibilities].
Topics: Adrenocorticotropic Hormone; Aged; Alzheimer Disease; Anticonvulsants; Brain; Catecholamines; Choline; Dementia; Dihydroergotoxine; Humans; Memory Disorders; Narcotic Antagonists; Nerve Tissue Proteins; Neuropsychology; Parasympatholytics; Phosphatidylcholines; Physostigmine; Piracetam; Trace Elements; Vasopressins; Vitamins | 1984 |
Chemotherapy of cognitive disorders in geriatric subjects.
Topics: Adrenocorticotropic Hormone; Aged; Aging; Alzheimer Disease; Arecoline; Brain Chemistry; Choline; Cognition Disorders; Cyclandelate; Electroencephalography; Humans; Memory; Methylphenidate; Pentylenetetrazole; Phosphatidylcholines; Physostigmine; Piracetam; Procaine; Vasodilator Agents; Vasopressins | 1984 |
Pharmacotherapy of aphasia: myth or reality?
Topics: Amphetamine; Aphasia; Bromocriptine; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Dopamine Agents; Fluoxetine; GABA Agonists; Humans; Indans; Neuroprotective Agents; Paroxetine; Physostigmine; Piperidines; Piracetam; Pyridines; Selective Serotonin Reuptake Inhibitors; Serotonin; Stroke; Zolpidem | 2007 |
2 trial(s) available for piracetam and physostigmine
| Article | Year |
|---|---|
Pharmacology of dementia.
Topics: 4-Aminopyridine; Acetylcholine; Adenosine Triphosphate; Aged; Aminopyridines; Central Nervous System Stimulants; Cerebrovascular Circulation; Clinical Trials as Topic; Dementia; Double-Blind Method; Humans; Levodopa; Nafronyl; Narcotic Antagonists; Nerve Tissue Proteins; Parasympathomimetics; Pentylenetetrazole; Physostigmine; Piracetam; Procainamide; Vasodilator Agents; Vasopressins | 1986 |
Cholinergic approaches to the treatment of Alzheimer's disease.
Topics: 4-Aminopyridine; Alanine; Alzheimer Disease; Aminopyridines; Arecoline; Clinical Trials as Topic; Humans; Parasympathomimetics; Physostigmine; Piracetam; Pyrrolidines; Research Design; Succinimides; Synapses | 1986 |
10 other study(ies) available for piracetam and physostigmine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
In silico studies, synthesis and pharmacological evaluation to explore multi-targeted approach for imidazole analogues as potential cholinesterase inhibitors with neuroprotective role for Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophorus; Female; Horses; Imidazoles; Male; Maze Learning; Memory Disorders; Mice; Molecular Structure; Neuroprotective Agents; Structure-Activity Relationship | 2018 |
[Effects of amiridin and tacrine, drugs effective in Alzheimer's disease, on synaptosomal uptake of neuromediators].
Topics: Alzheimer Disease; Aminoquinolines; Animals; Cholinesterase Inhibitors; Dopamine; Epinephrine; gamma-Aminobutyric Acid; Neurotransmitter Agents; Norepinephrine; Physostigmine; Piracetam; Psychotropic Drugs; Rats; Serotonin; Synaptosomes; Tacrine | 1992 |
Effect of different subtypes of cognition enhancers on long-term potentiation in the rat dentate gyrus in vivo.
Topics: Animals; Cognition; Ergoloid Mesylates; Hippocampus; Male; Neural Pathways; Physostigmine; Piracetam; Rats; Rats, Inbred Strains; Stimulation, Chemical; Time Factors; Vinca Alkaloids | 1992 |
[Study of anti-amnesic activity of amiridin in a model of amnesic syndrome].
Topics: Acetylcholinesterase; Alzheimer Disease; Aminoquinolines; Amnesia; Animals; Cerebral Cortex; Cholinesterase Inhibitors; In Vitro Techniques; Lipids; Male; Physostigmine; Piracetam; Psychotropic Drugs; Rats; Scopolamine; Synaptosomes; Syndrome; Tacrine | 1991 |
Effect of drugs acting on monoaminergic and cholinergic systems on the quantified EEG of rats.
Topics: Animals; Cerebral Cortex; Clonidine; Dose-Response Relationship, Drug; Electroencephalography; Evoked Potentials; Haloperidol; Locus Coeruleus; Male; Physostigmine; Piracetam; Psychotropic Drugs; Rats; Receptors, Adrenergic, alpha; Receptors, Cholinergic; Yohimbine | 1989 |
Radial maze as a tool for assessing the effect of drugs on the working memory of rats.
Topics: Amphetamine; Animals; Apomorphine; Male; Memory; Physostigmine; Piracetam; Rats; Scopolamine | 1982 |
The impairment of long-term potentiation in rats with medial septal lesion and its restoration by cognition enhancers.
Topics: Animals; Brain Injuries; Cerebellar Nuclei; Ergoloid Mesylates; Long-Term Potentiation; Male; Nootropic Agents; Physostigmine; Piracetam; Rats; Rats, Sprague-Dawley; Septal Nuclei; Vinca Alkaloids | 1994 |
Latency of memory consolidation induced in mice by piracetam, a nootropic agent.
Topics: Animals; Avoidance Learning; Male; Memory; Mice; Physostigmine; Piracetam; Time Factors | 1993 |
[Neuroprotective therapy of Alzheimer's disease?].
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Galantamine; Humans; Neuroprotective Agents; Physostigmine; Piracetam; Tacrine | 1996 |